Clinical Trial Update: Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of pembrolizumab after radiation therapy and chemotherapy in limited-stage small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer | Phase 2 | Status: TERMINATED